Nobel Biocare Holding AG (Nobel Biocare Holding AG) Change In Payables And Accrued Expense : $0.0 Mil (TTM As of Dec. 2013)

View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Change In Payables And Accrued Expense?

Nobel Biocare Holding AG's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2013 was $0.0 Mil. It means Nobel Biocare Holding AG's Accounts Payable & Accrued Expense stayed the same from Dec. 2012 to Dec. 2013 .

Nobel Biocare Holding AG's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2013 was $0.0 Mil. It means Nobel Biocare Holding AG's Accounts Payable & Accrued Expense stayed the same from Dec. 2012 to Dec. 2013 .

Nobel Biocare Holding AG Change In Payables And Accrued Expense Historical Data

The historical data trend for Nobel Biocare Holding AG's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Change In Payables And Accrued Expense Chart

Nobel Biocare Holding AG Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Change In Payables And Accrued Expense	Get a 7-Day Free Trial							-	-	-	-	-

Nobel Biocare Holding AG Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2013 was $0.0 Mil.

Nobel Biocare Holding AG Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nobelbiocare.com

Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines

From GuruFocus

The new NobelProcera� Zirconia Implant Bridge simplifies the partnership between clinicians and technicians

By PRNewswire PRNewswire • 02-08-2021

Mario Gabelli Comments on Nobel Biocare Holding AG

By Vera Yuan Vera Yuan • 10-28-2014